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Summary box
 Ź Qualitative evidence syntheses are useful for explor-
ing the effects of complex interventions and their 
subsequent implementation.
 Ź Question formulation is critical to the systematic re-
view and associated guideline processes yet current 
frameworks do not accommodate a complex sys-
tems or complex intervention perspective.
 Ź We review existing question formulation frameworks 
for qualitative evidence synthesis and report on their 
suitability for formulating questions to explore com-
plex interventions.
 Ź We propose an alternative question formulation 
framework, the PerSPEcTiF framework, to be further 
tested, to accommodate context, perspective, time 
and space within a complex system perspective
AbSTrACT
When making decisions about complex interventions, 
guideline development groups need to factor in the 
sociocultural acceptability of an intervention, as well as 
contextual factors that impact on the feasibility of that 
intervention. Qualitative evidence synthesis offers one 
method of exploring these issues. This paper considers the 
extent to which current methods of question formulation 
are meeting this challenge. It builds on a rapid review 
of 38 different frameworks for formulating questions. 
To be useful, a question framework should recognise 
context (as setting, environment or context); acknowledge 
the criticality of different stakeholder perspectives 
(differentiated from the target population); accommodate 
elements of time/timing and place; be sensitive to 
qualitative data (eg, eliciting themes or indings). None of 
the identiied frameworks satisied all four of these criteria. 
An innovative question framework, PerSPEcTiF, is proposed 
and retrospectively applied to a published WHO guideline 
for a complex intervention. Further testing and evaluation 
of the PerSPEcTiF framework is required.
InTroduCTIon
Many commentators seek to define complexity 
in connection with complex interventions.1 
Rogers distinguishes between simple, compli-
cated and complex: simple is encapsulated in 
following a recipe, complicated by sending a 
rocket to the moon and complex in bringing 
up a child.2 In the first paper of this WHO series 
on Complex Interventions, Petticrew and 
colleagues turn the emphasis away from the 
activity itself (intervention or exposure) and 
towards the perspective adopted by the evalu-
ator (in this case an ‘intervention perspective’ 
or a ‘systems perspective’).1 These perspec-
tives offer alternative evaluation ‘lenses’ to be 
adopted by reviewers or guideline developers 
even when examining the same phenom-
enon. For example, when examining use of a 
safety checklist within operating theatres3 one 
could either adopt an ‘intervention perspec-
tive’ or ‘lens’ to consider issues that relate to 
implementation within a controlled setting 
(the theatre) or adopt a ‘systems perspective’ 
or lens to explore the wider organisational or 
system culture within which the checklist is 
being implemented (eg, within a culture of 
blame or of improvement).
When making decisions about complex 
interventions, guideline development groups 
need to take account of the sociocultural 
acceptability of the intervention, as well as 
how feasible the intervention will be to imple-
ment. Complex interventions are inextricably 
linked to context; interventions interact with, 
and sometimes change, the context within 
which they are implemented.1 Recognition 
that complex interventions are context-depen-
dent not only holds implications for the effect 
of the intervention, but also for its sustain-
ability, acceptability and feasibility. This paper 
examines implications of adopting a ‘systems 
perspective’, as opposed to an ‘interventions 
perspective’, when formulating questions to 
be addressed by qualitative research. As with 
the first paper in the WHO Complex Inter-
ventions series,1 it focuses on the first part of 
the evidence synthesis process, defining the 
question. This paper reflects on frameworks 
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box 1 Complexity-related questions to be addressed in a 
qualitative evidence synthesis (QES)
Potential research questions for a QES 
 Ź How do the components work along and in combination to produce 
effects?
 Ź How do they interact to produce outcomes?
 Ź How and why does the implementation of the intervention vary 
across contexts?
 Ź How does the system change when the intervention is introduced?
 Ź What are the effects (anticipated and unanticipated) which follow 
from this system change?
 Ź How do effects change over time? (Changes may relate to biologi-
cal, ecological, epidemiological or social factors)
 Ź What explains how effectiveness of the intervention changes over 
time?
 Ź What factors enable or inhibit implementation of interventions?
 Ź What changes in processes and outcomes follow the introduction 
of this system change?
 Ź At what levels in the system are they experienced? (eg, individuals, 
families, communities)
 Ź To what extent do patients/beneiciaries value different health 
outcomes?
 Ź Is the intervention socioculturally acceptable to patients/beneicia-
ries as well as to those implementing it?
 Ź Is the intervention socioculturally acceptable to the public and other 
relevant stakeholder groups?
 Ź To what extent do patients/beneiciaries value different non-health 
outcomes?
 Ź How accessible—in terms of physical as well as informational ac-
cess—is the intervention across different population groups?
 Ź What are the barriers and facilitators to implementing the 
intervention?
Adapted from Petticrew1 and Rehfuess.8
for structuring systematic review questions, informed by a 
rapid review of existing frameworks, to evaluate their suit-
ability when exploring complex interventions. The paper 
proposes an alternative framework, the PerSPEcTiF 
framework, for further testing.
It is increasingly recognised that systematic reviews 
of effects do not adequately capture how or why the 
effects of complex interventions differ according to 
context.4 5 Decision makers are demanding different 
types of synthesis to provide such evidence. Qualitative 
evidence synthesis (QES), for example, increasingly 
contributes to recommendations from WHO and other 
guideline development processes.6 7 QES can provide 
evidence for diverse questions beyond those that typically 
relate to the feasibility and acceptability of complex inter-
ventions (see Box 1)4 8 9 QES can potentially provide rich 
data relating to the context of interventions, policies or 
conditions and the lived experiences, views and beliefs of 
those involved. However, typical question frameworks for 
QES do not adequately account for a complexity perspec-
tive,10 11 in particular they do not account for the presence 
and assimilation of multiple stakeholder perspectives or 
for the importance of contextual variation; critical if QES 
findings are to support holistic decision-making and if 
guidelines are to be applied with contextual sensitivity. 
As Squire and colleagues emphasise:
Such complexity … makes the task of formulating a good 
review question both more important and more difficult. 
Furthermore, given the expected heterogeneity, systemat-
ic review questions should go beyond simple effectiveness 
questions (eg, ‘does X work?’) to consider under what cir-
cumstances X works.10
Guideline development organisations, such as WHO, 
the National Institute for Health and Care Excellence in 
the UK and other members of the Guidelines Interna-
tional Network (G-I-N), need to develop guideline recom-
mendations that are feasible and acceptable to those 
planning, providing, implementing or receiving care. In 
turn, guideline development requires systematic review 
methodologies that explore the complexity of interven-
tions, the context in which they are implemented and, 
the emphasis of this paper, the lens or evaluation frame 
through which they are evaluated.12
How do guIdElInE QuESTIonS CurrEnTly rECognISE 
ComPlExITy?
Question formulation is critical to guideline develop-
ment13 because it determines both the priorities to be 
addressed by the guideline and the types of evidence 
that will subsequently be admitted when addressing these 
priorities. Systematic reviews typically specify the elements 
of a question using an epidemiological design frame-
work—population/patient; intervention; comparison; 
outcome(s); popularly known by the ‘PICO’ acronym14 
or, replacing intervention with exposure, with the non-in-
tervention formulation, PECO.15 Use of a PICO/PECO 
question within a guideline development process implic-
itly privileges an experimental/observational epidemio-
logical model. Notwithstanding this inherent incompati-
bility the PICO model persists within many QES.16 17
A systematic review team should routinely consider 
the potential added value of a complexity perspective 
for their review topic and work with guideline devel-
opers to decide whether a simple, complex intervention 
or complex system perspective is most appropriate and 
feasible for the review. The stage of question formulation 
thus offers a unique opportunity to surface and resolve 
issues that relate to such a complexity perspective.
As the example of a safety checklist illustrates, one 
cannot choose an appropriate perspective simply on the 
basis of intervention characteristics. Increasingly, health 
technology assessments, which have traditionally adopted 
an ‘intervention perspective’, are being encouraged to 
adopt a broader societal (and hence ‘systems’) perspec-
tive within the frameworks they use.18 19 Nevertheless, 
broadly speaking, questions relating to health technology 
assessment typically gravitate towards an ‘intervention 
perspective’ while those that arise within a public health 
context often adopt a ‘systems perspective’. Decisions on 
which overarching perspective to adopt must be based 
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on what is most useful and most practicable. A review 
team can only attain partial understanding of complexity 
and they may implicitly or explicitly overlook something 
which subsequently matters.
This choice between an ‘intervention perspective' and 
a ‘systems perspective’ holds clear implications for ques-
tion formulation. Where an ‘intervention perspective’ is 
to be adopted, a QES typically explores barriers or facil-
itators to implementation, or the acceptability of the 
intervention to individuals and populations. A complex 
intervention perspective may still be accommodated 
within a population-based and intervention-based frame-
work,14 or by use of frameworks that add either setting20 
or context.18 However, a ‘complex systems perspective’ 
for the same intervention makes the literature search and 
review process logistically demanding. Questions may be 
specified within an extended framework to specify the 
complexity of the decision problem, or, increasingly, 
review teams may articulate the problem within an a 
priori logic model,1 which may be open to ongoing revi-
sion and refinement throughout the review.10 19
FormulATIng ComPlExITy-rElATEd QuESTIonS To bE 
AddrESSEd In A QES
As described elsewhere within this series,1 8 guideline 
development groups consider issues that extend beyond 
effectiveness (what works) and cost-effectiveness (the 
cost–benefit of each option). Questions relate to inter-
vention components, interactions between them, how 
intervention components adapt to and are modified 
by the context, how the system adapts to change and 
the role of feedback loops and emergent changes on 
the overall system.1 Further questions align to the 
WHO-INTEGRATE framework.8 For example, concerns 
such as patient values in relation to health outcomes, 
safety, sociocultural acceptability, equity and equality 
and societal perspectives require different question 
frameworks and draw on diverse types of evidence. 
Both companion papers in this series1 2 rehearse why a 
complex systems perspective might be considered sepa-
rately from a complex intervention perspective and why 
a systems perspective could add value to the interven-
tion perspective. The resulting premise of this analysis is 
that review authors may consequently need to advance 
their complexity perspective beyond the typical PICO 
framework used in conventional reviews. Box 1 draws 
on earlier papers in this series to identify specific ques-
tions.4 8 The PICO framework does not easily accom-
modate a complexity perspective10 21 requiring an alter-
native framework for articulating the review question.
Previous commentators have identified the need to 
consider how a complex intervention is implemented 
(ie, feasibility) and the environment or context (ie, 
acceptability and meaningfulness) within which the 
intervention or programme is delivered. The GRADE 
Evidence to Decision (EtD) framework22 and the 
Joanna Briggs ‘FAME’ framework23 acknowledge that 
feasibility, appropriateness and meaningfulness must 
be recognised in the shift from ‘what works’ to ‘what 
happens’.21
A guideline development group should prioritise 
questions relating to contextual variation that cannot be 
addressed in a primary study or questions which could 
be asked in a primary study, but are addressed robustly 
across multiple contexts through synthesis (Box 1). 
Questions may relate to contextual variation (variation 
across study contexts or between study contexts and 
the target context) or to contextual sensitivity (how the 
intervention must be adapted or modified to recog-
nise contextual factors present in the target context). 
Questions addressed by a QES mirror those that can 
be answered by primary qualitative research. Clearly, 
questions that focus on differences in acceptability, 
delivery and implementation between interventions or 
programmes are better addressed through synthesis 
rather than by a single-context primary study. In 
contrast, a primary study is better equipped to identify 
nuances within a specific context. Simple PICO variants 
are unsuited to handle either the complexity inherent 
in any single complex intervention review question1 or 
the wide variation in question types and evidence types 
required for guideline development (as illustrated by 
the WHO-INTEGRATE framework).8 The collective 
experience of the authors is that question formulation 
frameworks for qualitative evidence syntheses should 
include elements relating to both context and stake-
holder perspective. Dissatisfaction with the suitability of 
PICO for constructing questions relating to feasibility 
or appropriateness has led to several alternatives being 
proposed. We therefore resolved to conduct a rapid 
review of existing question formulation frameworks to 
examine their suitability to accommodate a complexity 
perspective.
rEvIEwIng ExISTIng QuESTIon FormulATIon FrAmEworkS
We performed a rapid review for currently available 
frameworks for formulating questions. This was not a 
comprehensive methodological review; we sought to 
map question variants and to examine their suitability 
for capturing a complexity perspective. In the inter-
ests of transparency, methods and results of the rapid 
review are reported separately in online supplementary 
file 1. However, the focus of this particular analysis is on 
specifying a candidate framework that accommodates 
complexity perspectives, not on the underpinning 
technical process by which individual items for possible 
inclusion were identified.
Following review of 1481 references and 113 full-text 
citations, we identified 38 question formulation frame-
works (See online supplementary file 1 for full list of 
included references) which were evaluated for their 
suitability to accommodate a complexity perspective.
Based on the methodological literature relating to 
QES and complex interventions, the team considered 
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Table 1 Proposed question formulation framework for use of qualitative synthesis within guidelines
Per S P E (C) Ti F
Perspective Setting Phenomenon of 
interest/problem
Environment (optional 
Comparison)
Time/timing Findings
Table 2 Worked example of question formulation framework (PerSPectif, spice and PICO) for a qualitative synthesis
Per S P E (C) Ti F
From the 
perspective of a 
pregnant woman
In the setting 
of rural 
communities
How does the 
phenomenon of 
facility-based 
care
Within an 
environment of 
poor transport, 
infrastructure 
and 
geographically 
remote facilities
Compare with 
traditional birth 
attendants at 
home
In the time 
period up to 
and including 
childbirth
In relation to 
the woman's 
perceptions and 
experiences
Setting Perpective Interest, 
phenomenon of
Comparison Evaluation Missing
In the setting of 
rural communities
From the 
perspective of a 
pregnant woman
How does the 
phenomenon of 
facility-based 
care
Compare with 
traditional birth 
attendants at 
home
In relation to 
the woman’s 
perceptions and 
experiences?
Environment, 
time/timing
Population Intervention Comparison Outcome Missing
Pregnant 
women
Facility-based 
care
Traditional birth 
attendants at 
home
Women's 
perceptions and 
experiences
Setting
environment
time/timing
that to be useful a question framework should recog-
nise context (articulated as setting, environment or 
context)24; acknowledge the criticality of stakeholder 
perspective (differentiated from target population)25; 
accommodate elements of time/timing26 and place; 
be sensitive to qualitative data (in the sense of elic-
iting themes or findings, rather than quantitative 
outcomes).9 None of the identified frameworks satis-
fied all four criteria. We therefore concluded that 
none of the existing frameworks was entirely suited 
to capture a complexity perspective when addressing 
questions potentially answerable by qualitative evidence 
syntheses.
Based on our rapid review of the elements of ques-
tion formulation frameworks, we concluded that an 
optimal framework for use by guideline development 
groups would need to better incorporate elements of 
‘context’, currently missing from existing frameworks. 
‘Context’ encompasses temporal, spatial and societal 
dimensions1 and offers an umbrella term beneath 
which environment and setting are subsumed. We 
propose that ‘environment’ should exploit well-es-
tablished public health connotations of wider soci-
etal determinants and health service characteristics 
within which a service is delivered. In contrast, setting 
describes the point where interaction between service 
user and service provider takes place.61 Within these 
two overarching constructs, further granularity can be 
accommodated; so, for example, a narrative review of 
contextual factors influencing health committees in 
low-income and middle-income countries identified 
four overlapping conceptual spheres—community and 
society which would be nested under environment and 
health facilities and health administration which would 
be articulated under setting.
An optimal framework would also capture different 
stakeholder perspectives, such as the views of partners 
or carers or, in a health systems context, of wider societal 
stakeholders. Finally, the question framework should 
encourage guideline developers to consider qualitative 
data, using alternatives to ‘outcomes’, and acknowledge 
contextual variation in time and space. Because no 
existing framework accommodates these requirements, 
the authors devised an alternative, PerSPEcTiF. Table 1 
outlines the elements proposed in the PerSPEcTiF 
framework, which consolidates elements from existing 
question formulation frameworks.
Table 2 provides a worked example of a PerSPEcTiF 
question framework compared with the popular PICO 
and SPICE variants. Clear omissions of the latter two 
frameworks are flagged in the column ‘missing’. So 
SPICE overlooks important features of the wider envi-
ronment as well as temporal (time/timing) aspects 
while PICO omits not only these two elements but also 
the local context of setting.
Online supplementary table 1 illustrates the subse-
quent search strategy for this example. By prompting 
review authors to identify key areas of a complexity 
perspective beyond a typical PICO, the PerSPEcTiF 
framework assists team members to identify appropriate 
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box 2 Steps in the question formulation process for 
qualitative evidence syntheses (expanded from wHo13)
Step 1: generate an initial list of questions 
Step 2: decide whether a simple, complex intervention or complex 
system approach is most appropriate for this particular review 
Step 3: draft the key questions using a relevant question framework 
Step 4: list relevant stakeholder perspectives 
Step 5: review and revise 
Step 6: prioritise the keyquestions 
Step 7: order stakeholder perspectives according to their criticality to 
the implementation chain 
Step 8: inalise the key questions and the important and critical 
stakeholder perspectives
search terms. Articulating the review question in this 
way helps to identify how eligible studies differ in time, 
setting, stakeholder perspectives and surrounding 
environment.
QuESTIon FormulATIon In guIdElInE dEvEloPmEnT
According to the WHO handbook for guideline develop-
ment, question formulation requires an eight-step process 
(Box 2).13 Complex interventions generate numerous 
questions with implications for the scale and complexity of 
retrieval and synthesis. Below we use selected case studies 
to highlight where and how PerSPEcTiF could be used. 
Protocol development for a QES is iterative, not linear, 
starting with ‘guiding review questions’.27 For the WHO 
smoking in pregnancy guidelines, a Technical Secretariat 
listed scoping questions and outcomes related to tobacco 
use and secondhand smoke exposure. This list was 
reviewed and prioritised by international stakeholders. 
Scoping establishes whether a review question is feasible 
(the logistics) and where conceptual boundaries (inclu-
sion and exclusion criteria) lie.28 Question formulation 
helps a guideline development group to consider what 
is feasible and what is meaningful. Will the QES review 
team mirror the scope of an accompanying effectiveness 
review? If so, the team may use similar subject terms for 
the searches for both effectiveness and qualitative data. 
Alternatively, will a system perspective examine the expe-
rience of a condition,29 how the condition is viewed by 
health professionals or society at large and how imple-
mentation might occur30? While QES can accommo-
date either a complex system or a complex intervention 
perspective, health technology assessments and guide-
lines often favour the narrower, intervention perspective, 
mainly for pragmatic reasons.31
Types of questions addressed by QES include: ‘Does 
evidence show that an “effective” intervention is poorly 
accepted within its target context?’ ‘Do studies demon-
strate that an experimental intervention works subop-
timally in a “real world” context?’. At this stage, all 
questions are potentially valid. The guideline develop-
ment group and stakeholders need to agree on terms 
used when articulating each question.10 Questions for the 
WHO smoking in pregnancy guidelines required several 
consultations with the guideline development group 
prior to identifying and synthesising the best available 
evidence for each key question within a systematic review.
Step 2 involves drafting the prioritised key questions 
using a relevant question formulation framework. Ques-
tion formulation should ‘prompt review authors to iden-
tify the key components of the intervention/s and how 
these interact’.32 The PerSPEcTiF question formulation 
framework encourages this complexity perspective32 by 
acknowledging contextual variation of both time and 
space, and by using alternatives to ‘outcomes’. In addition, 
by including ‘perspective’ as an element, the PerSPEcTiF 
framework accommodates a ‘systems perspective’, with 
organisational levels and causal pathways10 (step 3), thus 
extending beyond the PICO format. Logic models offer 
an alternative way of thinking through such complexity1 
and may be revised throughout the review process, either 
opportunistically or at preplanned stages, as new data 
emerges.16.
Stakeholders are key when refining questions and 
‘lumping’ or ‘splitting’ interventions33 and outcomes10 
(steps 4–6). In prioritising questions to be addressed 
by qualitative evidence, guideline development groups 
need to agree which contextual factors are meaningful. 
This may require multiple iterations.7 Our rapid review 
revealed that current question frameworks fail to accom-
modate context. By incorporating ‘environment’ (the 
context within which a health service is delivered) and 
‘setting’ (the point where interaction between service 
user and service provider takes place), PerSPEcTiF seeks 
to address these limitations.
It is preferable to identify important contextual vari-
ables a priori, to inform study selection criteria. Alterna-
tively, they may emerge when analysing included studies, 
determining how the data extraction form is struc-
tured. Ideally, a review team would construct a simple 
typology of important contextual factors. The reality is 
demonstrably different, for example, grouping African 
countries by socioeconomic factors or by predominant 
religion results in different groupings. By considering 
the extent of contextual variation early, a guideline devel-
opment group not only shapes the final set of key ques-
tions but also informs data extraction and formulation of 
recommendations.
Having finalised the overarching guideline ques-
tion (step 7), this is broken down into key questions to 
be addressed within the guideline. Key questions must 
be clearly formulated and the guideline development 
group should consider whether each key question is 
best addressed by quantitative or qualitative evidence 
or by a combination of both. The review team should 
decide whether these key questions are best addressed by 
evidence retrieved by an overarching guideline search, 
with evidence sifted and mapped to each key question, 
or whether specific supplementary searches are required 
for each key question (step 8). Online supplementary 
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table 2 includes what should be considered at each stage 
of the question formulation process.
ConSIdErATIonS wHEn FormulATIng rEvIEw QuESTIonS 
For QES
In summary, systematic reviewers and guideline devel-
opers should decide whether a systematic review will 
adopt an ‘intervention perspective’ or extend a ‘systems 
perspective’ beyond the setting to include the wider envi-
ronment. An intervention perspective can use popula-
tion-based and intervention-based frameworks perhaps 
with the addition of context (eg, PICOC) or ‘setting’ 
(eg, SPICE). Where a ‘systems perspective’ offers 
insight a nuanced approach, using either the innovative 
PerSPEcTiF framework or a logic model structure is valu-
able.
PerSPEcTiF allows systematic reviewers and guideline 
developers to factor in contextual variation relating to 
time and/or space. Some variation can be anticipated; 
literature published prior to a particular date may be 
irrelevant to the decision in hand. Alternatively, the study 
contexts informing a particular guideline may emerge as 
substantively different from the target context and the 
review and guideline development teams may explic-
itly exclude such studies.34 The first paper in this series 
offers guidance on how teams might judge contextual 
relevance.4
If a QES accompanies a systematic review of quanti-
tative evidence, then teams must consider the extent to 
which the quantitative and qualitative review share the 
same question scope. As illustrated in the first paper 
of this series,1 quantitative and qualitative approaches 
are typically complementary with questions addressed 
variously by quantitative or qualitative evidence or by a 
combination of both.
Finally, we acknowledge that the type of question asked 
is not only determined by the perspective adopted by 
the guideline but also, in turn, influences selection of 
an appropriate method for qualitative, or mixed method 
synthesis. Guidance on how to select a QES method 
based, for example, on whether a question is ‘fixed or 
emerging’ is available35 36 and is considered in other 
papers in this series.37 38
We acknowledge that further work is required to test 
the utility of the PerSPEcTiF framework for the widest 
possible variety of questions addressed by QES. Simi-
larly, there is a need to look at the extent to which this 
framework elicits additional information, not otherwise 
identified by population-based and intervention-based 
frameworks, and, importantly, what the implications of 
the framework are on the subsequent construction of 
search strategies.
ConCluSIon
This paper highlights the need for focused, relevant 
questions in qualitative evidence syntheses that address 
a complexity perspective. Use of the PerSPEcTiF 
framework, where a systems perspective is to be employed, 
should result in more appropriate questions addressing, 
for example, feasibility and acceptability. Better formu-
lation of questions will, in turn, lead to more informed 
decisions on choice of synthesis method and, ultimately, 
to better evidence on aspects of context that are impor-
tant to consider when guidelines adopt a complexity 
perspective.
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